Massive study aims to unlock secrets of rare vascular diseases
NCT ID NCT03538639
First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 5 times
Summary
This study is collecting medical data and biological samples from people with genetic conditions affecting the heart and blood vessels, their relatives, and healthy volunteers. The goal is to better understand these diseases, improve diagnosis, and lay the groundwork for future treatments. Participants will undergo various tests like scans, blood draws, and heart function assessments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve diagnosis and understanding of rare vascular diseases, potentially paving the way for future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results depend on participant enrollment and data quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC MUTATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- A Million-Person quest to predict disease before it begins
- Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's
- Could your surroundings trigger a hidden genetic risk?
- Personalized dosing for kids with dystonia? new study investigates genetic factors
- Massive study aims to decode cancer genes for better family counseling